Popular topics to explore
10 Midcap stocks showing strong growth 👇
These stocks have 50%+ growth in both sales and profit, along with 50%+ 3-year sales and profit growth. 1. SPARC 2. Waaree Renewables 3. Jeena Sikho 4. V-Marc India 5. Manorama Industries 6. Fujiyama Power 7. Quality Power Electrical 8. Kr…
Stocks With Strong Future Guidance — Worth Tracking
• V-Marc
• RR Kabel
• Finolex
• HFCL HFCL
• E2E Networks
• MTAR Technologies
• Syrma SGS
• Netweb Technologies
• Sterlite Technologies
• Sansera Engineering
• Azad Engineering
• Omnitech Engineering
• Dynamatic Technologies
• Aequs
• Ross…
Launch of Calcium Gluconate Injection USP - Glenmark Pharmaceuticals Ltd
Code BSE: 532296 NSE: GLENMARK
Commenting on the launch, Marc Kikuchi, President & Business Head, North America, said, “The launch of Calcium Gluconate Injection USP marks another important step in strengthening Glenmark’s U.S. injectab…
Glenmark Pharmaceuticals shares rise after US FDA approval for Fluticasone nasal spray
GLENMARK cals
Glenmark Pharmaceuticals climbed about 1.4% in early trade on Thursday after the company received US Food and Drug Administration (FDA) approval for its Fluticasone Propionate Nasal Spray USP, 0.05 mg/spray.
On the National S…
Marc Technocrats Wins ₹4.5 Crore NHAI Project
Key Highlights Marc Technocrats has secured an Independent Engineer Services project from the National Highways Authority of India (NHAI) for a 6-lane Zirakpur Bypass. The project covers 19.2 km across Punjab and Haryana and has a contract…
NETWEB Stocks up more than +100% in last 1 year:
Swan Defence: +978%
Cupid: +852%
Sterlite Tech.: +518%
Sigma Advanced System: +515%
Modern Insulator: +462%
V-Marc India: +445%
MTAR Technologie: +388%
Midwest Gold: +387%
CIAN Agro: +337…
💊 **Glenmark's U.S. Arm Launches Methylene Blue Injection in the U.S. Market**
📅 **June 17, 2026** Glenmark Pharmaceuticals Inc., USA**, a subsidiary of **Glenmark Pharmaceuticals Ltd.**, has announced the launch of **Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial** in the United States. 🔹 Key…
Susan Electricals India IPO
These factors are Looking good: Industry Tailwinds: The wire and cable sector specifically copper/aluminum is currently enjoying strong market sentiment and high valuations, benefiting from rising commodity prices and infrastructure demand.…
Launch of Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials - Glenmark Pharmaceuticals Ltd
Code BSE: 532296 NSE: GLENMARK
Commenting on the launch, Marc Kikuchi, President & Business Head, North America said, “The launch of Lacosamide Injection USP reflects the disciplined execution of our strategy to build a broader, differe…
Mastek Ltd Latest Updates
MASTEK Significant Contract Wins
In March 2026, Mastek (UK) Ltd secured two major contracts with the UK Home Office. The first is a framework engineering contract worth £85 million (approx. ₹1,038 crore) to support and scale the ATLAS plat…
Launch Leucovorin Calcium - Glenmark Pharmaceuticals Ltd
Code BSE: 532296 NSE: GLENMARK
Glenmark Pharmaceuticals Inc., USA is pleased to announce the upcoming launch1 of Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial. Glenmark’s Leucovorin Calcium for Injection USP, 350 m…
80 stocks : Excellent Results 🔥🔥 - Market is rewarding great results - Only selected stocks with good results are firing 🔥 ✅ Save It 1. Pondy Oxides 2. Vintage Coffee 3. Denta Water 4. CCL Products 5. Interarch 6. Epacck Prefab 7. MCX…
**Glenmark Pharma to Launch Ropivacaine Hydrochloride Injection in the U.S. Market**
*Mumbai/New Jersey, October 23, 2025:* Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., announced the upcoming launch of **Ropivacaine Hydrochloride Injection USP** in the U.S. market. The injection will be…
2nd Sep 2025 · SEBI-Registered Analyst
RGvantage with Rajiv Gupta · 2nd Sep 2025
Launch of Eribulin Mesylate Injection - Glenmark Pharmaceuticals Lt
Code BSE: 532296 NSE: GLENMARK
Glenmark PharmaceuticalsInc., USA (Glenmark) is pleased to announce the upcoming launch1 of Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose
Vials. Glenmark’s Eribulin Mesylate Injection,…
Glenmark Pharmaceuticals USA to Launch Micafungin for Injection in September 2025
GLENMARK Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the upcoming launch of Micafungin for Injection USP, available in 50 mg/vial and 100 mg/vial single-dose vials. The product is bioequivalent…
7th Jul 2025 · SEBI-Registered Analyst
Stock Market with Hariom Rathor · 7th Jul 2025
Stock Market Wrap-Up | Closing Bell: Nifty and Sensex End Flat Amid Volatile Trade; HINDUNILVR Rises 3%, TECHM Slips 2%
Indian equity benchmarks closed largely unchanged on Monday, as strength in consumer and oil & gas sectors was offset by weakness in financial and IT stocks. Market sentiment remained cautious ahead of the upcoming July 9 U.S. tariff deadli…
📌 Stocks to Watch – July 7 Highlights
Here’s a quick look at the key market movers for today: Rail Vikas Nigam: Won a ₹143.4 crore order from Southern Railway to upgrade electric traction in Salem Division. Hazoor Multi Projects: Bagged a ₹913 crore solar project order in Guj…
" From Savers to Investors: Jio BlackRock’s SEBI Approval Sparks Brokerage Revolution "
- SEBI Nod for Brokerage Jio BlackRock Broking Pvt Ltd has secured a certificate of registration from SEBI to operate as a stockbroker and clearing member in India. - Who’s Behind It This new broking arm is a wholly owned subsidiary of J…
Jio Financial share price jumps almost 5%
With JioBlackRock Investment Advisers, we will be able to offer personalised advice to retail investors. Now with brokerage, we will also bring an execution platform for self-directed investors," said Marc Pilgrem, Managing Director and CEO…
10th May 2025 · SEBI-Registered Analyst
Foxers Consultancy (SEBI RA) · 10th May 2025
Co-working company International Workplace Group (IWG) sees India as the third-largest market
International Workplace Group (IWG), a global hybrid workspace platform with brands including Regus and Spaces, aims to become India's third-largest co-working centre provider within three to five years. The company currently operates 105 c…
